Platelet-activating factor (PAF) receptor antagonist (Ki = 1.3 µM)1. Inhibits neutrophil degranulation and superoxide production in vitro1. Inhibits PAF-induced bronchoconstriction in a guinea pig model2. Displays neuroprotective effects in various model
* VAT and and shipping costs not included. Errors and price changes excepted